About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Chinese Medical Journal
›
Top Articles
Chinese Medical Journal
2.9
(top 6%)
Impact Factor
3.1
(top 6%)
extended IF
59
(top 7%)
H-Index
573
authors
16.4K
papers
88K
citations
5.6K
citing journals
33K
citing authors
Most Cited Articles of Chinese Medical Journal
Title
Year
Citations
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
2020
831
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study
2020
619
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease
2020
580
Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients
2020
537
Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study
2020
432
Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)
2020
402
SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease
2010
277
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
2021
215
Observations on effect of sodium selenite in prevention of Keshan disease
1979
181
Antimalaria studies on Qinghaosu
1979
169
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
2020
159
Gut Microbiota-brain Axis
2016
159
Post-stroke antihypertensive treatment study. A preliminary result
1995
143
Epidemiologic studies on the etiologic relationship of selenium and Keshan disease
1979
132
Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro
2007
127
Prevalence of Nontraumatic Osteonecrosis of the Femoral Head and its Associated Risk Factors in the Chinese Population: Results from a Nationally Representative Survey
2015
125
Gossypol--a new antifertility agent for males
1978
100
Mindfulness Meditation for Primary Headache Pain: A Meta-Analysis
2018
99
Adipocytokines and breast cancer risk
2007
91
Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis
2020
89
Distribution of the COVID-19 epidemic and correlation with population emigration from Wuhan, China
2020
86
Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019
2020
84
Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro
2007
84
Guideline on prevention and treatment of chronic hepatitis B in China (2005)
2007
82
Announcement on raising exhibition items about history of Chinese Medical Association
2019
78
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.